In T-ALL, DNMT3A mutations frequently co-occur with NOTCH1 mutations and predict poor clinical outcomes.16, 17, 18 Although this mutational profile represents a minor fraction of adult patients with T-ALL overall, it represents a major population of difficult-to-treat cases with poor outcomes. Here, DNMT3A is linked to acute lymphoblastic leukemia.